top of page

iPSC
Organoid Core

Partnered With
The Neuro Logo
Patient-derived IPSCs and IPSC-generated organoids are first used to model the disease pathophysiology. This provides the closest in vitro model system to humans to delineate/uncover the underlying pathways that contribute to neurodegenerative diseases and further evaluate the efficacy of the therapeutics. Neurotherapeutics that pass this stage of validation are regarded as suitable for higher animal model testing.

MEET THE TEAM

Dr. Thomas Durcan headshot
DR. THOMAS DURCAN

TRIDENT Co-Principal Investigator and iPSC/Organoid Team Lead

Associate Professor, Department of Neurology and Neurosurgery,
McGill University

Director, The Neuro's Early Drug Discovery Unit (EDDU), McGill University


Email: 

thomas.durcan@mcgill.ca

​​​

Website:
https://www.mcgill.ca/neuro/thomas-durcan-phd
​
 

Dr. Edward Fon headshot
DR. EDWARD FON

TRIDENT Co-Principal Investigator and
iPSC/Organoid Team Lead


Professor, Department of Neurology
and Neurosurgery, McGill University

Scientific Director, The Neuro
(Montreal Neurological Institute-Hospital),
McGill University


 

Email: 

ted.fon@mcgill.ca

​​​

Website:
https://www.mcgill.ca/neuro/edward-fon-md-frcpc

Projects

Highly Qualified Personnel

paula_lepine-3-6826wx4556h-240dpi-2019-0

Paula Lepine

Research Associate

McGill University

Maria Trallero headshot

Maria Trallero

Research Associate

McGill University

20230718_120255_edited_edited_edited_edi

Wen Luo

Research Associate

McGill University

wolfgang_reintsch-2-6888wx4597h-240dpi-2

Wolfgang Reintsch

Research Associate

McGill University

emmanuelle_nguyen-renou-1-6168wx4119h-24

Emmanuelle Nguyen Renou

Research Associate

McGill University

bottom of page